From: Citibank, N.A.Warrant Agreement • February 12th, 2019 • Tabula Rasa HealthCare, Inc. • Services-business services, nec • New York
Contract Type FiledFebruary 12th, 2019 Company Industry JurisdictionTo: Tabula Rasa HealthCare, Inc. 228 Strawbridge Drive, Suite 100 Moorestown, NJ 08057 Attention: Chief Financial Officer Telephone No.: Facsimile No.: (856) 273-0254 (with such fax to be confirmed by telephone to (888) 974-2763, extension: )
From: Citibank, N.A.Warrant Agreement • February 12th, 2019 • Tabula Rasa HealthCare, Inc. • Services-business services, nec • New York
Contract Type FiledFebruary 12th, 2019 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Tabula Rasa HealthCare, Inc. (“Company”) to Citibank, N.A. (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party further agrees that this Confirmation together with the Agreement evidence a complete binding agreement between Company and Dealer as to the subject matter and terms of the Transaction to which this Confirmation relates, and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
November 12, 2018Warrant Agreement • November 16th, 2018 • Kbr, Inc. • Heavy construction other than bldg const - contractors • New York
Contract Type FiledNovember 16th, 2018 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by KBR, Inc. (“Company”) to Citibank, N.A. (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party further agrees that this Confirmation together with the Agreement evidence a complete binding agreement between Company and Dealer as to the subject matter and terms of the Transaction to which this Confirmation relates, and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
JPMorgan Chase Bank, National Association London Branch 25 Bank Street Canary Wharf London E14 5JP EnglandWarrant Agreement • August 7th, 2015 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Ironwood Pharmaceutical, Inc. (“Company”) to JPMorgan Chase Bank, National Association, London Branch (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements with respect to the Transaction and serve as the final documentation for the Transaction.
Re: Additional WarrantsWarrant Agreement • August 7th, 2015 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Ironwood Pharmaceutical, Inc. (“Company”) to Credit Suisse Capital LLC (“Dealer”), represented by Credit Suisse Securities (USA) LLC (“Agent”) as its agent, as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements with respect to the Transaction and serve as the final documentation for the Transaction.
Re: Additional WarrantsWarrant Agreement • August 7th, 2015 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Ironwood Pharmaceutical, Inc. (“Company”) to JPMorgan Chase Bank, National Association, London Branch (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements with respect to the Transaction and serve as the final documentation for the Transaction.
RBC Capital Markets, LLC 3 World Financial Center 200 Vesey Street New York, New York 10281 Telephone: (212) 858-7000Warrant Agreement • February 14th, 2014 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 14th, 2014 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by AMAG Pharmaceuticals, Inc. (“Company”) to Royal Bank of Canada (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for the Transaction.
Chesterbrook, PA 19087 Attention: Jim Fickenscher, Chief Financial Officer Telephone No.: (484) 321 – 5902 Facsimile No.: (484) 321 – 5996 Email: jfickenscher@auxilium.com Re: Additional WarrantsWarrant Agreement • January 29th, 2013 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 29th, 2013 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Auxilium Pharmaceuticals, Inc. (“Company”) to Goldman, Sachs & Co. (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for the Transaction.
Chesterbrook, PA 19087 Attention: Jim Fickenscher, Chief Financial Officer Telephone No.: (484) 321 – 5902 Facsimile No.: (484) 321 – 5996 Email: jfickenscher@auxilium.com Re: Additional WarrantsWarrant Agreement • January 29th, 2013 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 29th, 2013 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Auxilium Pharmaceuticals, Inc. (“Company”) to JPMorgan Chase Bank, National Association, London Branch (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for the Transaction.
Barclays Bank PLC Canary Wharf, London E14 4BB England c/o Barclays Capital Inc. as Agent for Barclays Bank PLC New York, NY 10019Warrant Agreement • June 3rd, 2009 • Take Two Interactive Software Inc • Services-prepackaged software • New York
Contract Type FiledJune 3rd, 2009 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Take-Two Interactive Software, Inc. (“Company”) to Barclays Bank PLC (“Dealer”), represented by Barclays Capital Inc. (“Agent”), as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction. Dealer is regulated by the Financial Services Authority. Dealer is not a member of the Securities Investor Protection Corporation (“SIPC”).
JPMorgan Chase Bank, National Association London EC4Y 0JP England May 28, 2009 To: Take-Two Interactive Software, Inc.Warrant Agreement • June 3rd, 2009 • Take Two Interactive Software Inc • Services-prepackaged software • New York
Contract Type FiledJune 3rd, 2009 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Take-Two Interactive Software, Inc. (“Company”) to JPMorgan Chase Bank, National Association, London Branch (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
New York, New York Attention: Treasurer Telephone No.: (646) 536-2842 Facsimile No.: (646) 941-3566 Re: Additional WarrantsWarrant Agreement • June 3rd, 2009 • Take Two Interactive Software Inc • Services-prepackaged software • New York
Contract Type FiledJune 3rd, 2009 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Take-Two Interactive Software, Inc. (“Company”) to JPMorgan Chase Bank, National Association, London Branch (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
Barclays Bank PLC Canary Wharf, London E14 4BB England c/o Barclays Capital Inc. as Agent for Barclays Bank PLC New York, NY 10019Warrant Agreement • June 3rd, 2009 • Take Two Interactive Software Inc • Services-prepackaged software • New York
Contract Type FiledJune 3rd, 2009 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Take-Two Interactive Software, Inc. (“Company”) to Barclays Bank PLC (“Dealer”), represented by Barclays Capital Inc. (“Agent”), as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction. Dealer is regulated by the Financial Services Authority. Dealer is not a member of the Securities Investor Protection Corporation (“SIPC”).